PHARMACOTHERAPY OF SYSTEMIC AUTOIMMUNE DISEASES IN CONDITIONS OF THE COVID-19 PANDEMIC: INNOVATIVE EXPERIMENTAL STUDY
Open Access
- 19 June 2021
- journal article
- Published by RS Global Sp. z O.O. in Science Review
Abstract
The article presents the results of an innovative experimental study of pharmacotherapy of systemic autoimmune diseases in a pandemic of coronavirus infection is a timely and socially oriented way. The methodology of conducting a content analysis based on the theoretical principles of pharmaceutical and medical law and its components. Author used the method of drug selection developed by the Department of Medical and Pharmaceutical Law, General and Clinical Pharmacy of the Kharkiv Medical Academy of Postgraduate Education. Content analysis was performed by dosage forms by grouping them using the Sturgess formula, followed by the construction of discrete series of variations and distribution polygon. Received data made possible to state, that in some circumstances, doctors have a choice of both drugs and dosage forms. However, the data obtained show a lack of balance between supply and demand for patients and physicians. The analysis allows to obtain a complete description of the balance of "supply and demand" between the range and types of dosage forms of drugs INN Silymarin ATC code A05BA03, that approved for use.Keywords
This publication has 10 references indexed in Scilit:
- Pharmacotherapy of Systemic Vasculitis Combined with Cryoglobulinemic Syndrome Using Pharmacoeconomic ApproachesGlobal Journal of Health Science, 2021
- Pharmacotherapy of Immunopathological Syndromes Among Patients with Systemic Lupus Erythematosus Based on ABC/VEN AnalysisActa Scientific Medical Sciences, 2021
- System of drugs circulation based on medical and pharmaceutical lawActual Problems of Medicine and Pharmacy, 2021
- Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)Rheumatology Science and Practice, 2020
- Coronavirus Disease Pandemia 2019: Growth of Epidemic DangersActa Scientific Pharmaceutical Sciences, 2020
- Контент-аналіз аптечних закладів України, де виготовляють екстемпоральні лікарські засобиHealth of Society, 2017
- Content analysis of efficacy descriptions on branded pharmaceutical websitesJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2012
- Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic DiseasesJournal of Immunology Research, 2011
- Autoimmune diseaseThe Lancet, 2006
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005